Oct
2026
Fiera Milano, Italy
Visit us
stand 18J75, Finished Dosage & Formulation
Multicare Egypt for Pharma. Industries
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:Egypt
-
On CPHI since:2023
-
Certificates:3
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 18J75, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Bone Care
Bone Care is Alfacalcidol ( vitamin D analogue) used for the management of hypocalcemia, secondary hyperparathyroidism, and osteodystrophy in patients with chronic renal failure, as well as some types of rickets and osteomalacia. -
Product Olanvexa ODT
Olanvexa is used to treat schizophrenia. It may also be used alone or with other medicines (eg, lithium or valproate) to treat mania or mixed episodes that is part of bipolar disorder (manic-depressive illness). -
Product Perdofenex Cap
Perdofenex is used for the treatment of idiopathic pulmonary fibrosis (fibrosis of the lungs with an unknown cause). Pirfenidone is in a class of medications called pyridones. -
Product Trigastacare Capsule in capsule
Trigastacare capsules are a combination antimicrobial product containing bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride for oral administration. Each size hard gelatin capsule contains: Bismuth subcitrate potassium, 140 mg Metronidazole, 125 mg smaller capsule containing tetrac... -
Product Aripipracare
Aripipracare is a medication used to manage and treat schizophrenia, mania associated with bipolar I disorder, irritability associated with an autism spectrum disorder, disjunctive therapy in major depressive disorder, and Tourette syndrome. It is a second-generation antipsychotic medication




